MBL Materials Co., Ltd.
6 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Previously recorded as JSR Life Sciences Corporation (to 2026)
0
Ending by 2030
Oct 2034
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due May 5, 2027The maintenance fee for Solid Support, Ligand-Bound Solid Support, Detection or Separation Method for Target Substance, Solid Support Production Method, and Ligand-Bound Solid Support Production Method (US 10,466,235) comes due May 5, 2027. Unpaid by Nov 5, 2027, it lapses early.
- 1 fee due Sep 24, 2027The maintenance fee for Surface Treatment Agent for Surface Configured from Inorganic Material, Tool and Device Having Modified Surface, and Method for Manufacturing Tool and Device (US 10,597,540) comes due Sep 24, 2027. Unpaid by Mar 24, 2028, it lapses early.
- 1 fee due Nov 5, 2027The maintenance fee for Lens Solution, Contact Lens, and Production Method Therefor (US 10,640,732) comes due Nov 5, 2027. Unpaid by May 5, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,597,540 | Surface Treatment Agent for Surface Configured from Inorganic Material, Tool and Device Having Modified Surface, and Method for Manufacturing Tool and Device In force · High confidence | In force | High confidence | |
| US 10,139,402 | Separation Method, Detection Method, Signal Measurement Method, Method for Determining Disease, Method for Evaluating Drug Efficacy of Disease Treatment Drug, Kit, and Liquid Composition In force · High confidence | In force | High confidence | |
| US 10,640,732 | Lens Solution, Contact Lens, and Production Method Therefor In force · High confidence | In force | High confidence | |
| US 10,139,401 | Method for Capturing Target Substance, Solid-Phase Carrier for Capturing Target Substance, and Method for Producing Solid-Phase Carrier In force · High confidence | In force | High confidence | |
| US 9,958,445 | Solid-Phase Support, Ligand-Binding Solid-Phase Support, Method for Detecting or Separating Target Substance, and Method for Producing the Solid-Phase Support In force · High confidence | In force | High confidence | |
| US 10,788,487 | Solid-Phase Support, Ligand-Binding Solid-Phase Support, Method for Detecting or Separating Target Substance, and Method for Producing the Solid-Phase Support In force · High confidence | In force | High confidence | |
| US 11,125,747 | Solid Phase Carrier, Ligand-Bound Solid Phase Carrier, Method for Detecting or Separating Target Substance, and Method for Producing Solid Phase Carrier In force · High confidence | In force | High confidence | |
| US 10,466,235 | Solid Support, Ligand-Bound Solid Support, Detection or Separation Method for Target Substance, Solid Support Production Method, and Ligand-Bound Solid Support Production Method In force · High confidence | In force | High confidence | |
| US 10,976,473 | Method for Producing Medical Device and Medical Device In force · Medium confidence | In force | Medium confidence | |
| US 10,774,165 | Polymer Composition, Article, Medical Device, Article Production Method, and Cell Cluster Production Method In force · Medium confidence | In force | Medium confidence |
Also on record, not counted in the 15: 6 patents in force now held by others. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.